Literature DB >> 6977003

Methicillin-resistant Staphylococcus aureus: microbiologic characteristics, antimicrobial susceptibilities, and assessment of virulence of an epidemic strain.

J E Peacock, D R Moorman, R P Wenzel, G L Mandell.   

Abstract

An epidemic strain of methicillin-resistant Staphylococcus aureus (MRSA) isolated from patients at the University of Virginia Hospital in Charlottesville (MRSA-Va) was characterized, and virulence properties were compared with those of three clinically significant strains of methicillin-sensitive S. aureus. Unlike most known strains of MRSA, MRSA-Va was sensitive to tetracycline and streptomycin and exhibited high-level homogeneous methicillin resistance (minimal inhibitory concentration, greater than 128 microgram/ml). The expression of resistance was not influenced by incubation temperature. MRSA-Va contained significantly more catalase (P less than 0.05) than methicillin-sensitive strains but about the same amount of protein A. Phagocytosis and killing of MRSA-Va by normal polymorphonuclear leukocytes were not significantly different from that of the Wood-46 strain of S. aureus. In mouse virulence studies using both intraperitoneal and intravenous modes of infection, 50% lethal doses for MRSA-Va were comparable with those of the three methicillin-sensitive strains. This epidemic strain of MRSA appears to be fully virulent.

Entities:  

Mesh:

Substances:

Year:  1981        PMID: 6977003     DOI: 10.1093/infdis/144.6.575

Source DB:  PubMed          Journal:  J Infect Dis        ISSN: 0022-1899            Impact factor:   5.226


  33 in total

Review 1.  Nasal carriage of Staphylococcus aureus: epidemiology, underlying mechanisms, and associated risks.

Authors:  J Kluytmans; A van Belkum; H Verbrugh
Journal:  Clin Microbiol Rev       Date:  1997-07       Impact factor: 26.132

2.  Methicillin-Resistant Staphylococcus aureus Infections.

Authors: 
Journal:  Curr Infect Dis Rep       Date:  1999-10       Impact factor: 3.725

Review 3.  Consequences of the interaction of beta-lactam antibiotics with penicillin binding proteins from sensitive and resistant Staphylococcus aureus strains.

Authors:  H Labischinski
Journal:  Med Microbiol Immunol       Date:  1992       Impact factor: 3.402

4.  Characterization of resistance phenotype and cephalosporin activity in oxacillin-resistant Staphylococcus aureus.

Authors:  M Mateos-Mora; C C Knapp; J A Washington
Journal:  Antimicrob Agents Chemother       Date:  1988-02       Impact factor: 5.191

5.  In vitro synergistic activity between meropenem and other beta-lactams against methicillin-resistant Staphylococcus aureus.

Authors:  Y Sumita; S Mitsuhashi
Journal:  Eur J Clin Microbiol Infect Dis       Date:  1991-02       Impact factor: 3.267

6.  Staying one jump ahead of resistant Staphylococcus aureus.

Authors:  P J Sanderson
Journal:  Br Med J (Clin Res Ed)       Date:  1986-09-06

7.  A comparison of clinical features and mortality among methicillin-resistant and methicillin-sensitive strains of Staphylococcus aureus endocarditis.

Authors:  Hee Jung Yoon; Jun Yong Choi; Chang Oh Kim; June Myung Kim; Young Goo Song
Journal:  Yonsei Med J       Date:  2005-08-31       Impact factor: 2.759

8.  In vitro activities of teichomycin, fusidic acid, flucloxacillin, fosfomycin, and vancomycin against methicillin-resistant Staphylococcus aureus.

Authors:  S H Guenthner; R P Wenzel
Journal:  Antimicrob Agents Chemother       Date:  1984-08       Impact factor: 5.191

9.  Methicillin-resistant Staphylococcus aureus in Europe.

Authors:  A Voss; D Milatovic; C Wallrauch-Schwarz; V T Rosdahl; I Braveny
Journal:  Eur J Clin Microbiol Infect Dis       Date:  1994-01       Impact factor: 3.267

10.  Efficacies of rapid agglutination tests for identification of methicillin-resistant staphylococcal strains as Staphylococcus aureus.

Authors:  J Piper; T Hadfield; F McCleskey; M Evans; S Friedstrom; P Lauderdale; R Winn
Journal:  J Clin Microbiol       Date:  1988-09       Impact factor: 5.948

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.